Brilliance Phototherapy Device
Brilliant Phototherapy Device is a neonatal jaundice treatment device.
Brilliance Phototherapy Device is a blue LED-based phototherapy device for treatment of neonatal jaundice.
61 Countries in Europe, Africa, South America, Asia, and Australia
Phoenix Medical Systems Private Ltd in Chennai India manufactures, distributes, and sells Brilliance under a license from D-Rev
Goal 3: Good health and well-being
Hospitals and clinics with neonatal intensive care units (NICUs) or special newborn care units (SNCUs) in developing countries.
Manufactured in India
For sale globally through Phoenix Medical Systems. Users can submit an enquiry form or contact the manufacturer through the phone.
As of 2015, 1,204 units have been installed in 15 countries. Interview with designer, May 2015
As of 2020, over 960,000 babies have been treated with Brilliance Phototherapy Device in 61 countries.
* Overall Dimensions: 159.5 cm (height) x 71 cm (width) x 71 cm (depth)
* Light Unit Dimensions: 57.5 cm (length) x 36 cm (width) x 6 cm (depth)
* Total Unit Mass: 20 kg
* Footprint of Stand: 71 cm (length) x 71 cm (width) x 13 cm (depth)
* Height of Base <7.5 cm
* Castors: 2 Lockable
* Height Adjustment Range: 110 cm-160 cm (distance between bottom surface and ground)
* Recommended treatment distance: 35 cm
* Electrical supply: voltage 100-240 VAC ~; frequency 50/60 Hz
* Max power consumption: 60 W
More information can be found here.
Several hours of training are required for physicians, nurses, or midwives who will be responsible for placing infant under the device and overseeing their care.
Brilliance LEDs last up to 120,000 hours and will not need to be replaced for the life of the device. Use of LEDs has minimized maintenance requirements as they require replacement every 10 years compared to other common phototherapy devices that use compact fluorescent light bulbs that require replacement every 3-5 months.
Product has a lifetime of 10 years with proper care and maintenance (assuming 18 hrs usage per day). Warranty information available from Phoenix Medical Systems.
Manufacturer specified performance targets include: able to operate in areas of unreliable power supply, low cost, easy to use, portable.
During tests at Stanford University School of Medicine, Brilliance outperformed state-of-the-art phototherapy devices (that often cost upwards of $3,000 USD). Brilliance was also found to meet American Academy of Pediatrics standards for effective jaundice treatment Brilliance received CE mark in October 2013, certifying that the product meets European Union standards for safety and quality.
Error in obtaining the proper distance between the patient and the phototherapy device can result in under or over dose to the patient. The device has a built-in over temperature cut off to maintain safe temperatures.
Eye covers, Gonad covers, Bassinet
V. K. Cline et. al., Evaluation of an Affordable LED Phototherapy Device for Resource-Limited Settings, in 2011 Pediatric Academic Societies (PAS) and Asian Society for Pediatric Research (ASPR), 2011.
M. C. Juarez and A. L. Grossberg, “Phototherapy in the Pediatric Population,” Dermatologic Clinics, vol. 38, no. 1. W.B. Saunders, pp. 91–108, 01-Jan-2020, doi: 10.1016/j.det.2019.08.012.
R. Pugashetti and J. Koo, Phototherapy in Pediatric Patients: Choosing the Appropriate Treatment Option, YSDER, vol. 29, pp. 115–120, 2010, doi: 10.1016/j.sder.2010.03.006.
A. Pašić et al., Phototherapy in pediatric patients, Pediatr. Dermatol., vol. 20, no. 1, pp. 71–77, Jan. 2003, doi: 10.1046/j.1525-1470.2003.03016.x.
Stanford University study used the Standardized Bench Method (as referenced by: VremanHJ, Wong RJ, Murdock JR, Stevenson DK. Standardized bench method for evaluating the efficacy of phototherapy devices. Acta Paediatr 2008; 97: 308-316.)
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.